Search details
1.
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.
Lancet
; 391(10121): 659-667, 2018 02 17.
Article
in English
| MEDLINE | ID: mdl-29241979
Results
1 -
1
de 1
1
Next >
>>